EUVIMEDEUVIMED entdecken
Crossref

Comorbidities and predictors of unfavorable prognosis in hypersensitivity pneumonitis

N. V. Trushenko, B. B. Lavginova, Iu. A. Levina, E. S. Pershina

Meditsinskiy sovet = Medical Council · 14.07.2026 · (9) · 142-149

DOI: 10.21518/ms2026-200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 14.07.2026. Verfasst von N. V. Trushenko und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease characterized by inflammation and/or pulmonary fibrosis. Fibrotic HP (fHP) is associated with an unfavorable prognosis, however, the impact of comorbidities on disease progression and outcomes remains insufficiently studied.

Aim

To assess the prevalence and clinical significance of comorbidities and to identify predictors of disease progression and mortality in patients with fibrotic and non-fibrotic HP (non-fHP). Materials and methods . This prospective observational study included 392 patients with multidisciplinary-confirmed HP. The follow-up period was 12 months. Clinical, functional, and radiological characteristics, Charlson comorbidity index, 6-minute walk test (6-MWT), echocardiographic parameters were evaluated. Disease progression was assessed according to the ATS/ ERS/JRS/ALAT 2022 criteria. Logistic regression and ROC analyses were used to identify predictors of progression and mortality.

Results

A total of 339 patients were included in the analysis: 89.9% with fHP and 11.1% with non-fHP. Patients with fHP were older and demonstrated higher GAP scores, more severe dyspnea and cough, poorer 6-MWT performance, and higher mortality compared with non-fHP. Patients with fHP also had higher Charlson comorbidity index values (4 (2-5) vs 2 (1-4), p = 0.003) and a higher prevalence of cardiovascular diseases. A usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography was an independent predictor of progression (OR 3.16, 95% CI 1.06–9.46). Predictors of mortality included unidentified causative antigen exposure, oxygen desaturation at the end of the 6-MWT, Charlson comorbidity index ≥ 4, and left ventricular ejection fraction ≤ 55%. Diabetes mellitus was also associated with an increased risk of progression and mortality (OR 2.58, 95% CI 1.19–5.56, p = 0.016).

Conclusion

Patients with fHP are characterized by a high burden of comorbidities, particularly cardiovascular diseases and diabetes mellitus. UIP pattern, unidentified causative antigen exposure, significant oxygen desaturation during the 6-MWT, and a high Charlson comorbidity index have a substantial impact on disease prognosis.

Zitieren

APA

Trushenko, N. V., Lavginova, B. B., Levina, I. A., & Pershina, E. S. (2026). Comorbidities and predictors of unfavorable prognosis in hypersensitivity pneumonitis. Meditsinskiy sovet = Medical Council, 142-149. https://doi.org/10.21518/ms2026-200

Vancouver

Trushenko NV, Lavginova BB, Levina IA, Pershina ES. Comorbidities and predictors of unfavorable prognosis in hypersensitivity pneumonitis. Meditsinskiy sovet = Medical Council. 2026:142-149. doi:10.21518/ms2026-200

BibTeX
@article{Trushenko2026,
  author = {Trushenko, N. V. and Lavginova, B. B. and Levina, Iu. A. and Pershina, E. S.},
  title = {Comorbidities and predictors of unfavorable prognosis in hypersensitivity pneumonitis},
  journal = {Meditsinskiy sovet = Medical Council},
  year = {2026},
  number = {9},
  pages = {142--149},
  doi = {10.21518/ms2026-200}
}
Kostenlos starten →